ABIT:XETRA:XETRA-AXA IM ACT Biodiversity Equity UCITS ETF - USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 12.188

Change

0.00 (0.00)%

Market Cap

N/A

Volume

78.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing ABIT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.99% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.99% 69% C- 69% C-
Trailing 12 Months  
Capital Gain 23.69% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.69% 72% C 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.60% 58% F 57% F
Dividend Return 7.60% 57% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.92% 66% D+ 73% C
Risk Adjusted Return 85.19% 81% B- 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike